MedPro Rx, Inc. Awards 49 Scholarships to Students Nationwide
Specialty Pharmacy Has Donated Nearly $300,000 Through “Education Is Power” Program
Raleigh, NC, September 24, 2011 --(PR.com)-- Nancy McFarlane, president of MedPro Rx, Inc. (http://www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses who need clotting factor, IVIg and other medication, has announced that the pharmacy awarded 49 scholarships in 16 states as part of its 2011 scholarship program. Since starting its “Education is Power” scholarship program in 2006, MedPro Rx has distributed nearly $300,000 to students nationwide who have either hemophilia or von Willebrand Disease (vWD). The annual scholarships are open to U.S. residents who are living with a bleeding disorder, entering or attending a community college, junior college, four-year college, university or vocational school, and active in their community.
Hemophilia is a rare, hereditary disorder that causes excessive bleeding to occur spontaneously or after injury. The bleeding may be external or internal into joints, muscles, the abdominal cavity, the brain and other organs. Hemophilia affects approximately 20,000 people nationwide, crossing all racial and socioeconomic groups, with a higher incidence among males. The three most common types of hemophilia are Hemophilia A or Factor VIII Deficiency, Hemophilia B or Factor IX Deficiency, and von Willebrand Disease (vWD). Von Willebrand Disease is caused by a deficiency or defect of a clotting protein, and it affects approximately 1-2 percent of the United States population. Unlike hemophilia, vWD occurs equally among males and females and is more likely to cause nosebleeds and bleeding under the skin than into the joints.
For more information about MedPro Rx’s “Education is Power” program or its pharmacy services, visit http://www.medprorx.com or call (888) 571-3100.
Quotes:
“We at MedPro Rx are pleased that for the sixth consecutive year, our ‘Education Is Power’ program is able to support students living with bleeding disorders who want to study at institutes of higher learning,” said McFarlane. “Our commitment remains strong to supporting the hemophilia community with this opportunity.”
New Media Content:
MedPro Rx Blog
http://medprorx.blogspot.com/
MedPro Rx Facebook:
http://www.facebook.com/#!/MedProRx
About MedPro Rx, Inc.:
MedPro Rx, Inc. is a specialty infusion pharmacy, serving clients who require clotting factor, IVIg and other medications for complex chronic conditions. Established in Raleigh, N.C., in 2002, MedPro Rx’s team has more than 250 years of combined pharmacy, nursing and management experience. MedPro Rx, an Accreditation Commission for Health Care, Inc. provider (ACHC), emphasizes treatments for individuals with autoimmune neuromuscular disorders as well as rare bleeding disorders, such as hemophilia and von Willebrand Disease. The pharmacy has received numerous awards for its success and was recognized with the 2011 No. 1 top small business in the Triangle and the No. 2 small business in the south by Business Leader, won Triangle Business Journal’s Fast 50 award from 2008 – 2010 and was named among the nation’s fastest-growing companies by the Inc. 5000 award in 2010 and 2011. For more information about MedPro Rx, call (888) 571-3100 or visit http://www.medprorx.com/.
Erin Smith
MMI Public Relations
(919) 233-6600
erin@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com
###
Hemophilia is a rare, hereditary disorder that causes excessive bleeding to occur spontaneously or after injury. The bleeding may be external or internal into joints, muscles, the abdominal cavity, the brain and other organs. Hemophilia affects approximately 20,000 people nationwide, crossing all racial and socioeconomic groups, with a higher incidence among males. The three most common types of hemophilia are Hemophilia A or Factor VIII Deficiency, Hemophilia B or Factor IX Deficiency, and von Willebrand Disease (vWD). Von Willebrand Disease is caused by a deficiency or defect of a clotting protein, and it affects approximately 1-2 percent of the United States population. Unlike hemophilia, vWD occurs equally among males and females and is more likely to cause nosebleeds and bleeding under the skin than into the joints.
For more information about MedPro Rx’s “Education is Power” program or its pharmacy services, visit http://www.medprorx.com or call (888) 571-3100.
Quotes:
“We at MedPro Rx are pleased that for the sixth consecutive year, our ‘Education Is Power’ program is able to support students living with bleeding disorders who want to study at institutes of higher learning,” said McFarlane. “Our commitment remains strong to supporting the hemophilia community with this opportunity.”
New Media Content:
MedPro Rx Blog
http://medprorx.blogspot.com/
MedPro Rx Facebook:
http://www.facebook.com/#!/MedProRx
About MedPro Rx, Inc.:
MedPro Rx, Inc. is a specialty infusion pharmacy, serving clients who require clotting factor, IVIg and other medications for complex chronic conditions. Established in Raleigh, N.C., in 2002, MedPro Rx’s team has more than 250 years of combined pharmacy, nursing and management experience. MedPro Rx, an Accreditation Commission for Health Care, Inc. provider (ACHC), emphasizes treatments for individuals with autoimmune neuromuscular disorders as well as rare bleeding disorders, such as hemophilia and von Willebrand Disease. The pharmacy has received numerous awards for its success and was recognized with the 2011 No. 1 top small business in the Triangle and the No. 2 small business in the south by Business Leader, won Triangle Business Journal’s Fast 50 award from 2008 – 2010 and was named among the nation’s fastest-growing companies by the Inc. 5000 award in 2010 and 2011. For more information about MedPro Rx, call (888) 571-3100 or visit http://www.medprorx.com/.
Erin Smith
MMI Public Relations
(919) 233-6600
erin@mmipublicrelations.com
http://twitter.com/MMIPR
http://www.mmipublicrelations.com
###
Contact
MedPro Rx, Inc.
Patty Briguglio
919-233-6600
www.mmipublicrelations.com
Patty Briguglio
919-233-6600
www.mmipublicrelations.com
Contact
Categories